Turmeric

Anti-inflammatory and anticancer activities of furanodiene

Anti-inflammatory and anticancer activities of furanodiene

Furanodiene is option lithe component of turmeric oil that exhibits versus-inflammatory problem. In one chemical analysis, furanodiene and furanodienone were shown to suppress TPA-induced inflammation of mouse ears by 75 and 53%, respectively, at a dose of 1.0 mol [100]. Interestingly, the activities of furanodiene and furanodienone were comparable to those of indomethacin, the normally used related along together in the middle of-inflammatory agent. Furanodienone has been shown to suppress the proliferation of a broad variety of tumor cells including hepatocellular carcinoma [101], leukemia [102], uterine cervical cancer [103], and breast cancer [104] cells. Furanodiene-induced apoptosis is mediated through caspase activation, DNA fragmentation, and p38 MAPK activation. In a recent psychoanalysis, furanodiene significantly inhibited proliferation and increased lactate dehydrogenase general pardon in breast cancer cells [105]. Depolarization in mitochondrial membrane potential, chromatin synopsis, and DNA fragmentation were moreover observed after furanodiene treatment. Furanodiene induced cell cycle arrest atthe G0/G1 phase and significantly inhibited the discussion of p-cyclin D1, quantity cyclin D1, p-CDK2, quantity CDK2, p-Rb, sum Rb, Bcl-xL, and Akt. The protein expressions of Bad and Bax, and proteolytic cleavage of caspase-9, caspase-7, and poly ADP ribose polymerase (PARP), were dramatically increased. Furthermore, caspase inhibitor markedly reversed furanodiene-induced cell cytotoxicity, proteolytic cleavage of caspase-9, and DNA fragmentation but did not moving picture the proteolytic cleavage of PARP, whereas an Akt inhibitor enhanced furanodiene-induced cytotoxicity and PARP cleavage. In adding going on taking place, furanodiene dose-dependently suppressed tumor ensue in vivo, achieving 32 and 54% inhibition rates after intraperitoneal injection of 15 and 30 mg/kg, respectively. Furanodiene was with shown to upregulate TNFR1 [102] and exhibited sealed in opposition to-angiogenic bustle about endothelial cells [106]. When examined for pharmacokinetics, it was found to be intensely bioavailable, bearing in mind oral bioavailability of 49% at 10 mg/kg in rats [107].